Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.

This study tested a new drug, 611, in 142 Chinese adults with moderate to severe COPD. The goal was to see if it improves lung function and is safe compared to a placebo over 16 weeks. Participants were aged 40 to 85 and had a history of smoking.

This study tested a new medicine called 601 against an existing drug (ranibizumab) for people with vision loss due to a blocked vein in the retina (BRVO). Both drugs are injected into the eye to reduce swelling and improve sight. The trial involved 351 adults and measured how wel…

This study tested a new medicine called 611 in 519 Chinese adults with moderate to severe atopic dermatitis (eczema). The drug works by blocking a protein involved in inflammation. The main goal was to see if it could significantly improve skin symptoms like redness and itching a…